This is a very important mechanism in HNSCC, where ANXA6 promotes PKCalfa-mediated EGFR inactivation, acting as a scaffold for PKCalfa and promoting its recruitment to plasma membrane and its interaction with EGFR. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.